BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

409 related articles for article (PubMed ID: 23276981)

  • 21. Cellular and molecular neurosurgery: pathways from concept to reality--part I: target disorders and concept approaches to gene therapy of the central nervous system.
    Zlokovic BV; Apuzzo ML
    Neurosurgery; 1997 Apr; 40(4):789-803; discussion 803-4. PubMed ID: 9092853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defective viral vectors as agents for gene transfer in the nervous system.
    Kaplitt MG; Makimura H
    J Neurosci Methods; 1997 Jan; 71(1):125-32. PubMed ID: 9125381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune responses to adenovirus and adeno-associated vectors used for gene therapy of brain diseases: the role of immunological synapses in understanding the cell biology of neuroimmune interactions.
    Lowenstein PR; Mandel RJ; Xiong WD; Kroeger K; Castro MG
    Curr Gene Ther; 2007 Oct; 7(5):347-60. PubMed ID: 17979681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latest development in viral vectors for gene therapy.
    Lundstrom K
    Trends Biotechnol; 2003 Mar; 21(3):117-22. PubMed ID: 12628368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and molecular neurosurgery: pathways from concept to reality--part II: vector systems and delivery methodologies for gene therapy of the central nervous system.
    Zlokovic BV; Apuzzo ML
    Neurosurgery; 1997 Apr; 40(4):805-12; discussion 812-3. PubMed ID: 9092854
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Destination Brain: the Past, Present, and Future of Therapeutic Gene Delivery.
    Joshi CR; Labhasetwar V; Ghorpade A
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):51-83. PubMed ID: 28160121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing gene delivery vectors for the treatment of heart disease.
    Gray SJ; Samulski RJ
    Expert Opin Biol Ther; 2008 Jul; 8(7):911-22. PubMed ID: 18549322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adeno-associated virus and lentivirus vectors: a refined toolkit for the central nervous system.
    Blessing D; Déglon N
    Curr Opin Virol; 2016 Dec; 21():61-66. PubMed ID: 27559630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-viral nanosystems for gene and small interfering RNA delivery to the central nervous system: formulating the solution.
    O'Mahony AM; Godinho BM; Cryan JF; O'Driscoll CM
    J Pharm Sci; 2013 Oct; 102(10):3469-84. PubMed ID: 23893329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. AAV-PHP.B Administration Results in a Differential Pattern of CNS Biodistribution in Non-human Primates Compared with Mice.
    Liguore WA; Domire JS; Button D; Wang Y; Dufour BD; Srinivasan S; McBride JL
    Mol Ther; 2019 Nov; 27(11):2018-2037. PubMed ID: 31420242
    [TBL] [Abstract][Full Text] [Related]  

  • 31.
    Marcó S; Haurigot V; Bosch F
    Hum Gene Ther; 2019 Oct; 30(10):1211-1221. PubMed ID: 31482754
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gene therapy applications of viral vectors.
    Lundstrom K
    Technol Cancer Res Treat; 2004 Oct; 3(5):467-77. PubMed ID: 15453812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9.
    Saraiva J; Nobre RJ; Pereira de Almeida L
    J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vector systems for gene transfer to joints.
    Oligino TJ; Yao Q; Ghivizzani SC; Robbins P
    Clin Orthop Relat Res; 2000 Oct; (379 Suppl):S17-30. PubMed ID: 11039748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Applications of gene therapy to the CNS.
    Blömer U; Naldini L; Verma IM; Trono D; Gage FH
    Hum Mol Genet; 1996; 5 Spec No():1397-404. PubMed ID: 8875243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adeno-associated virus vectors for gene transfer to the brain.
    Okada T; Nomoto T; Shimazaki K; Lijun W; Lu Y; Matsushita T; Mizukami H; Urabe M; Hanazono Y; Kume A; Muramatsu S; Nakano I; Ozawa K
    Methods; 2002 Oct; 28(2):237-47. PubMed ID: 12413422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene transfer for cerebrovascular disease.
    Khurana VG; Katusic ZS
    Curr Cardiol Rep; 2001 Jan; 3(1):10-6. PubMed ID: 11139793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene therapy for stroke: 2006 overview.
    Chu Y; Miller JD; Heistad DD
    Curr Hypertens Rep; 2007 Mar; 9(1):19-24. PubMed ID: 17362667
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    Batista AR; King OD; Reardon CP; Davis C; Shankaracharya ; Philip V; Gray-Edwards H; Aronin N; Lutz C; Landers J; Sena-Esteves M
    Hum Gene Ther; 2020 Jan; 31(1-2):90-102. PubMed ID: 31696742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene transfer into the central nervous system in vivo using a recombinanat lentivirus vector.
    Lai Z; Brady RO
    J Neurosci Res; 2002 Feb; 67(3):363-71. PubMed ID: 11813241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.